Join us at the 12^th Annual Alzheimer’s & Parkinson’s Drug Development Summit

BioPharma Diagnostics executives will attend the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit, set to take place in Boston, Massachusetts, from April 23 –25. They will be available to meet with attendees to discuss how our capabilities and data can accelerate biopharmaceutical and clinical research initiatives.

BioPharma Diagnostics offers biopharmaceutical companies:

• The preeminent collection of biomedical data, with more than 7M longitudinal clinical datasets, including structured and unstructured data, digitized pathology images, and more. All data is independently certified as de-identified.
• A large and diverse diagnostic test menu spanning the full range of subspecialties, including the leading menu of esoteric testing.
• Diagnostic test development, validation, and commercialization through Mayo Clinic Laboratories.
• Biobank and prospective sample collections for the generation of molecular datasets.
• Clinical expertise in trial design, data, artificial intelligence algorithms, and diagnostic development.
• Committed, timely, and consistent support at every clinical trial phase.
• Highest quality standards, including extensive experience providing logistics and courier support.

Join us at the Alzheimer’s & Parkinson’s Drug Development Summit to learn how these collaborations enable us to deliver an end-to-end laboratory testing solution for your clinical trials.